More than 300 experts have written to the Prime minister calling for public health to come first

2022-04-25 0 By

Xinhua News Agency London, January 29 (reporter Guo Shuang)More than 320 researchers, academics and public health experts have written to Prime Minister Boris Johnson calling on the UK to take action to help developing countries get COVID-19 vaccines and put public health ahead of commercial interests.From Harvard University, Stanford university, the university of Oxford, Cambridge university researchers and institutions by the British emergency science advisory group of experts jointly signed after the letter, and that the letter is based on the variation will be coronavirus Mr Mick Dijon strain speed transmission and future mutant strains pose a threat to public health concerns.’Vaccinating the vast majority of the world’s population against COVID-19 is an excellent way to prevent novel coronavirus variants,’ the letter said.However, more than 3 billion people worldwide have yet to receive their first dose of COVID-19 vaccine, and large numbers of people in low – and middle-income countries remain unvaccinated, potentially leading to the emergence of new strains of the Novel Coronavirus.The emergence of the omicron strain in Africa, a continent with relatively low vaccination rates, is a stark warning of global inequities in vaccine supply.More than 91% of people over the age of 12 in the UK have received at least one dose of COVID-19 vaccine, more than 84% have received two doses and more than 64% have received a booster jab, according to government figures released on Monday.The letter calls on the UK Government to support, under the relevant agreement, the temporary exemption of INTELLECTUAL property rights (IPR) protection for vaccines, tests and treatments related to Novel Coronavirus so as to scale up vaccine production and diversify the research and development of COVID-19 prevention tools to end the epidemic as soon as possible.The letter also calls on the UK government to do all it can to get pharmaceutical companies to share mRNA(messenger RNA) vaccine technology to boost access to COVID-19 vaccines in low and middle-income countries.’The outbreak has not stopped at the UK border,’ the letter said. ‘Ensuring the vaccine reaches the world will help prevent human loss and the emergence of more worrying mutated strains, including those that could be more infectious, dangerous or make existing vaccines less effective.’Experts called on the UK government to put public health ahead of the commercial interests of the pharmaceutical industry to prevent further uncertainty and tragedy this year.